Combi-Elasto Evaluation of the Degree of Liver Fibrosis in Children with Cholestatic Liver Disease

Combi-Elasto Evaluation of the Degree of Liver Fibrosis in Children with Cholestatic Liver Disease

Cholestatic liver disease is a common liver disease in infants and young children. Liver fibrosis is a key factor affecting the prognosis, and liver transplantation is the only treatment option for liver cirrhosis. This study aimed to explore the efficacy of Combi-elasto for diagnosing liver fibrosi...

Full description

Bibliographic Details
Main Authors:	Rina Li, Caihui Hu, Fenglin Xu, Qi Zhang, Fazhi Zhou, Chenpeng Zheng, Yang Gao, Yi Tang, Jingyu Chen
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Diagnostics
Subjects:	child cholestatic liver disease liver fibrosis combi-elasto
Online Access:	https://www.mdpi.com/2075-4418/13/20/3229

Similar Items

Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism
by: Dino Šisl, et al.
Published: (2022-05-01)

Upregulation of cadherin‐11 contributes to cholestatic liver fibrosis
by: Bo Wu, et al.
Published: (2022-06-01)

Gut microbiome in liver pathophysiology and cholestatic liver disease
by: Shengmin Yan, et al.
Published: (2021-09-01)

The Role of Inflammation in Cholestatic Liver Injury
by: Chen J, et al.
Published: (2023-10-01)

Pruritus in chronic cholestatic liver diseases
by: E. V. Vinnitskaya, et al.
Published: (2017-12-01)

Effect of Vitamin B5 on Liver Enzyme Levels in Bile Duct Ligation Cholestatic Rat Model
by: Fatemeh Sadat Emami, et al.
Published: (2017-01-01)

Induced Endothelial Cell-Integrated Liver Assembloids Promote Hepatic Maturation and Therapeutic Effect on Cholestatic Liver Fibrosis
by: Donggyu Nam, et al.
Published: (2022-07-01)

Changes in intestinal fungal diversity and compositions in patients with cholestatic liver disease
by: LI Zhen, et al.
Published: (2022-06-01)

Characteristics of gut microbiota and their correlation with clinical parameters in patients with cholestatic liver disease
by: WU Lingyi, et al.
Published: (2020-11-01)

Secondary Malnutrition and Nutritional Intervention in Cholestatic Liver Diseases in Infants
by: Alfredo Larrosa-Haro, et al.
Published: (2021-11-01)

Astragalus saponins and its main constituents ameliorate ductular reaction and liver fibrosis in a mouse model of DDC-induced cholestatic liver disease
by: Linzhang Zhang, et al.
Published: (2022-10-01)

Quality of life among patients suffering from cholestatic liver disease-induced pruritus: A systematic review
by: Xin Yee Jin, et al.
Published: (2016-09-01)

Alpha-ketoglutarate alleviates cholestatic liver injury in mice
by: XIE Yuhong, et al.
Published: (2022-07-01)

Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
by: Qingmiao Shi, et al.
Published: (2023-05-01)

The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
by: Hiroaki Fuji, et al.
Published: (2021-12-01)

Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses
by: Shuni Duan, et al.
Published: (2024-02-01)

New-onset severe hypercholesterolemia in a patient with cholestatic liver disease. Should we treat the lipids?
by: Panteleimon E. Papakonstantinou, et al.
Published: (2017-07-01)

Heme Oxygenase-1 Induction by Cobalt Protoporphyrin Ameliorates Cholestatic Liver Disease in a Xenobiotic-Induced Murine Model
by: Jung-Yeon Kim, et al.
Published: (2021-07-01)

Protective Effects of Bee Venom-Derived Phospholipase A<sub>2</sub> against Cholestatic Liver Disease in Mice
by: Jung-Yeon Kim, et al.
Published: (2021-08-01)

Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
by: Lisheng Chen, et al.
Published: (2021-08-01)

Severe liver dysfunction in an infant with cystic fibrosis masquerading as metabolic liver disease
by: K P Srikanth, et al.
Published: (2016-01-01)

Single-Cell Transcriptomes Reveal Characteristic Features of Mouse Hepatocytes with Liver Cholestatic Injury
by: Na Chang, et al.
Published: (2019-09-01)

Clinical and genetic study of ABCB4 gene-related cholestatic liver disease in China: children and adults
by: Lili Cao, et al.
Published: (2024-04-01)

Novel compound heterozygote mutations of TJP2 in a Chinese child with progressive cholestatic liver disease
by: Ting Ge, et al.
Published: (2019-01-01)

The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
by: Takahiro Nishio, et al.
Published: (2022-10-01)

Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice
by: Zhenya Guo, et al.
Published: (2022-01-01)

Ketamine restriction correlates with reduced cholestatic liver injury and improved outcomes in critically ill patients with burn injury
by: Christian De Tymowski, et al.
Published: (2024-02-01)

Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves’s disease: a case report and literature review
by: Jinhui Zeng, et al.
Published: (2021-09-01)

Oral clindamycin causing acute cholestatic hepatitis without ductopenia: a brief review of idiosyncratic drug-induced liver injury and a case report
by: Harsha Moole, et al.
Published: (2015-10-01)

Cholestatic Liver Injury in a Patient with Tertiary Syphilis
by: Sahaj Mujumdar, et al.
Published: (2022-09-01)

Costunolide alleviated DDC induced ductular reaction and inflammatory response in murine model of cholestatic liver disease
by: Juan Hao, et al.
Published: (2023-07-01)

First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder
by: Nawal Al Nahdi, et al.
Published: (2013-01-01)

Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury
by: Andrea Villar-Lorenzo, et al.
Published: (2019-07-01)

Cholestatic Liver Disease and Pregnancy: A Systematic Review and Meta-Analysis
by: Bryan Ferrigno, et al.
Published: (2022-02-01)

Reversal of cholestatic liver disease by the inhibition of sphingosine 1-phosphate receptor 2 signaling
by: Huiling Cao, et al.
Published: (2024-01-01)

JCAD, a new potential therapeutic target in cholestatic liver disease
by: Byoung Kuk Jang
Published: (2024-04-01)

Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study
by: Jiaqi Yang, et al.
Published: (2024-01-01)

Uncovering key molecules and immune landscape in cholestatic liver injury: implications for pathogenesis and drug therapy
by: Shuailing Song, et al.
Published: (2023-05-01)

Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study
by: Antonia Greimel, et al.
Published: (2023-11-01)

The Role of Gut Microbiota in Mice With Bile Duct Ligation-Evoked Cholestatic Liver Disease-Related Cognitive Dysfunction
by: Bowen Yang, et al.
Published: (2022-05-01)